Entyvio® ,
Vedolizumab
Disease
Crohn's disease
,
Ulcerative colitis
,
Drug Class
Biologics/Biosimilars
Delivery Method
IV
or
Injection
or
Brand name:
Entyvio®
,
Drug name:
Vedolizumab
Drug type
Integrin Receptor Antagonist
Recommendations for pregnancy
No human data; likely low risk
Recommendations for breastfeeding
No human data
Most common side effects
Common side effects include injection site reactions, naspharyngitis, headache, pain in joints, nausea, fever, upper respiratory infections, fatigue.
Other
An allergic reaction can happen during or after the infusion (rash; itching; swelling of lips, tongue, throat or face; shortness of breath; heart palpitations), there have been reports of infections, and liver problems can occur. To see the full prescribing information for this medication, click here.
Learn more about
Biologics/Biosimilars